Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.

Li HX, Lu ZH, Shen K, Cheng WJ, Malpica A, Zhang J, Wei JJ, Zhang ZH, Liu J.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):848-57. eCollection 2014. Review.

2.

Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?

Gao FF, Bhargava R, Yang H, Li Z, Zhao C.

Hum Pathol. 2013 Aug;44(8):1534-43. doi: 10.1016/j.humpath.2012.12.007. Epub 2013 Mar 1.

PMID:
23465279
4.

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R.

Am J Surg Pathol. 2010 Oct;34(10):1407-16. doi: 10.1097/PAS.0b013e3181ef7b16. Erratum in: Am J Surg Pathol. 2010 Dec;34(12):1891.

PMID:
20861711
5.

The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer.

Koç N, Ayas S, Uygur L.

Gynecol Oncol. 2014 Sep;134(3):486-91. doi: 10.1016/j.ygyno.2014.07.089. Epub 2014 Jul 17.

PMID:
25038287
6.

Serous Tubal Intraepithelial Carcinoma Associated With Extraovarian Metastases.

Schneider S, Heikaus S, Harter P, Heitz F, Grimm C, Ataseven B, Prader S, Kurzeder C, Ebel T, Traut A, du Bois A.

Int J Gynecol Cancer. 2017 Mar;27(3):444-451. doi: 10.1097/IGC.0000000000000920.

PMID:
28187099
7.

Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.

Mittal N, Srinivasan R, Gupta N, Rajwanshi A, Nijhawan R, Gautam U, Sood S, Dhaliwal L.

Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):481-488. doi: 10.4103/0377-4929.191789.

8.

p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.

Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC.

Int J Gynecol Pathol. 2011 Sep;30(5):417-24. doi: 10.1097/PGP.0b013e318216d447.

PMID:
21804388
9.

[Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].

Zhao RJ, Wang YY, Li Z, Wu KY, Kong LF, Zheng WX.

Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):542-547. doi: 10.3760/cma.j.issn.0529-5807.2017.08.005. Chinese.

PMID:
28810294
10.

In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.

Yamamoto Y, Ning G, Howitt BE, Mehra K, Wu L, Wang X, Hong Y, Kern F, Wei TS, Zhang T, Nagarajan N, Basuli D, Torti S, Brewer M, Choolani M, McKeon F, Crum CP, Xian W.

J Pathol. 2016 Mar;238(4):519-530. doi: 10.1002/path.4649. Epub 2016 Jan 9.

11.

Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.

Morrison JC, Blanco LZ Jr, Vang R, Ronnett BM.

Am J Surg Pathol. 2015 Apr;39(4):442-53. doi: 10.1097/PAS.0000000000000352.

PMID:
25517955
12.

[Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].

Wen J, Shi JL, Shen DH, Chen YX, Song QJ.

Zhonghua Bing Li Xue Za Zhi. 2012 Jul;41(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2012.07.001. Chinese.

PMID:
22932451
13.

Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.

Malmberg K, Klynning C, Flöter-Rådestad A, Carlson JW.

Virchows Arch. 2016 Jun;468(6):707-13. doi: 10.1007/s00428-016-1928-7. Epub 2016 Mar 22.

PMID:
27003156
14.

Changes in the Extracellular Matrix Are Associated With the Development of Serous Tubal Intraepithelial Carcinoma Into High-Grade Serous Carcinoma.

van der Steen SCHA, Bulten J, Van de Vijver KK, van Kuppevelt TH, Massuger LFAG.

Int J Gynecol Cancer. 2017 Jul;27(6):1072-1081. doi: 10.1097/IGC.0000000000000933.

PMID:
28333845
15.

Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases.

Tang S, Onuma K, Deb P, Wang E, Lytwyn A, Sur M, Daya D.

Int J Gynecol Pathol. 2012 Mar;31(2):103-10. doi: 10.1097/PGP.0b013e31822ea955.

PMID:
22317864
16.

Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas.

Horn LC, Kafkova S, Leonhardt K, Kellner C, Einenkel J.

Int J Gynecol Pathol. 2013 Jul;32(4):339-44. doi: 10.1097/PGP.0b013e31826a629b.

PMID:
23722505
17.

Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?

Mahe E, Tang S, Deb P, Sur M, Lytwyn A, Daya D.

Int J Gynecol Pathol. 2013 Jul;32(4):353-7. doi: 10.1097/PGP.0b013e318264ae09.

PMID:
23722507
18.

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.

Kuhn E, Meeker A, Wang TL, Sehdev AS, Kurman RJ, Shih IeM.

Am J Surg Pathol. 2010 Jun;34(6):829-36. doi: 10.1097/PAS.0b013e3181dcede7.

19.

Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.

Gilks CB, Irving J, Köbel M, Lee C, Singh N, Wilkinson N, McCluggage WG.

Am J Surg Pathol. 2015 Mar;39(3):357-64. doi: 10.1097/PAS.0000000000000353.

PMID:
25517954
20.

The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.

Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, Ferguson SE.

J Obstet Gynaecol Can. 2014 Feb;36(2):133-140. doi: 10.1016/S1701-2163(15)30659-9. Review.

PMID:
24518912

Supplemental Content

Support Center